Evidence map›Paper›PMID 18804346›Full record

ArticleSchizophrenia research2008

Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia.

Todd L Edwards, Xu Wang, Qi Chen, Brandon Wormly, Brien Riley, F Anthony O'Neill, Dermot Walsh, Marylyn D Ritchie, Kenneth S Kendler, Xiangning Chen

Open access · greenAbstract read
In one paragraph

Article in Schizophrenia research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Association Analysis Between SNPs in the Promoter Region ofNeuropsychiatric disease and treatment · 2020
    Article
  2. Role of the β Common (βc) Family of Cytokines in Health and Disease.Cold Spring Harbor perspectives in biology · 2018
    Review
  3. Genetics of schizophrenia from a clinicial perspective.International review of psychiatry (Abingdon, England) · 2012
    Review
  4. Methamphetamine-associated psychosis.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2012
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Todd L EdwardsCenter for Human Genetics Research, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Xu Wang
Qi Chen
Brandon Wormly
Brien Riley
F Anthony O'Neill
Dermot Walsh
Marylyn D Ritchie
Kenneth S Kendler
Xiangning Chen
Virginia Commonwealth University · USCenter for Human Genetics · USHealth Research Board · IEQueen's University Belfast · GBVanderbilt University Medical Center · US

Funding

THE GENETIC EPIDEMIOLOGY OF SCHIZOPHRENIA IN IRELANDR01MH041953 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI KENDLER, KENNETH SEEDMAN · 1987 to 2008
$5.2M
NIMH NIH HHS R01 MH041953NIMH NIH HHS R01MH41953
6 · The paper itself

Abstract

Schizophrenia is a common psychotic mental disorder that is believed to result from the effects of multiple genetic and environmental factors. In this study, we explored gene-gene interactions and main effects in both case-control (657 cases and 411 controls) and family-based (273 families, 1,350 subjects) datasets of English or Irish ancestry. Fifty three markers in 8 genes were genotyped in the family sample and 44 markers in 7 genes were genotyped in the case-control sample. The Multifactor Dimensionality Reduction Pedigree Disequilibrium Test (MDR-PDT) was used to examine epistasis in the family dataset and a 3-locus model was identified (permuted p=0.003). The 3-locus model involved the IL3 (rs2069803), RGS4 (rs2661319), and DTNBP1 (rs2619539) genes. We used MDR to analyze the case-control dataset containing the same markers typed in the RGS4, IL3 and DTNBP1 genes and found evidence of a joint effect between IL3 (rs31400) and DTNBP1 (rs760761) (cross-validation consistency 4/5, balanced prediction accuracy=56.84%, p=0.019). While this is not a direct replication, the results obtained from both the family and case-control samples collectively suggest that IL3 and DTNBP1 are likely to interact and jointly contribute to increase risk for schizophrenia. We also observed a significant main effect in DTNBP1, which survived correction for multiple comparisons, and numerous nominally significant effects in several genes.

Indexed as

Carrier ProteinsChromosomes, Human, Pair 5DysbindinDystrophin-Associated ProteinsFemaleGene FrequencyGenetic MarkersGenetic Predisposition to DiseaseGenotypeHaplotypesHumansInterleukin-3MaleModels, GeneticPedigreePolymorphism, Single NucleotideCarrier ProteinsDTNBP1 protein, humanDysbindinDystrophin-Associated ProteinsGenetic MarkersInterleukin-3

Identifiers

PMID18804346
PMCPMC2746913
OpenAlexW1988199258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.